The human granulocytic ehrlichiosis (HGE) agent, which replicates in neutrophils, was found not to induce superoxide anion (O 2 ؊ ) generation or extracellular release by human peripheral blood neutrophils, as measured by a luminol-dependent chemiluminescence assay or a cytochrome c reduction assay, respectively. Furthermore, the HGE agent completely prevented O 2 ؊ release by neutrophils upon stimulation with phorbol myristate acetate (PMA), formylmethionyl-leucyl-phenylalanine, or Escherichia coli. The inhibition was HGE agent dose dependent, required ehrlichial contact with the host cells, and was reversible upon removal of the extracellular HGE agent bound to the host cells prior to PMA stimulation. Structural integrity of or new protein synthesis by the HGE agent was not required for the inhibition; carbohydrate but not surface protein of the HGE agent was required. The HGE agent did not prevent O 2 ؊ generation in human peripheral blood monocytes derived from the same individual. This neutrophil-specific prevention of O 2 ؊ generation by the HGE agent would be critical in survival of the HGE agent. This is the first demonstration of the rapid inhibition of preexisting NADPH oxidase in human neutrophils by the HGE agent.
An emerging tick-borne zoonosis caused by the human granulocytic ehrlichiosis (HGE) agent was first described in 1994 (5) and has been increasingly recognized in the United States and several European countries. HGE is a disease characterized by systemic illness such as fever, chills, headache, malaise, and/or myalgia. Laboratory tests may reveal thrombocytopenia, leukopenia, elevated C-reactive protein levels, and elevated liver enzyme activities. The HGE agent is a unique obligatory intracellular bacterium that replicates in neutrophils. Neutrophils have a strong ability to kill invading microorganisms through activation of the NADPH oxidase, which rapidly generates superoxide anion (O 2 Ϫ ) and subsequent formation of other bactericidal reactive oxygen intermediates (hydrogen peroxide, myeloperoxide, hypochlorous acid, hydroxyl radical, or longer-lived N-chloroamines) (1, 7, 9) . Recently Banerjee et al. (4) reported that after 5 days of infection with the HGE agent, HL-60 cells (a human promyelocytic leukemia cell line) exhibited a lack of luminol-dependent chemiluminescence (LDCL) response to phorbol myristate acetate (PMA) and down regulation of mRNA of gp91 phox , one component of the NADPH complex. However, for the HGE agent to survive in neutrophils, this inhibition must occur immediately rather than 5 days after establishment of infection. Although use of neutrophils is more difficult than use of cell lines, we determined whether human peripheral blood neutrophils produce O 2 Ϫ upon exposure to the HGE agent. Since we found that the HGE agent does not induce O 2 Ϫ generation, we determined whether this is a generalized and/or active inhibition and whether both intracellular and extracellular O 2 Ϫ generation is prevented. We further examined what type of ehrlichial factors and interactions between the HGE agent and neutrophils are required for this inhibition. Such data will provide new insights into a unique capability of the HGE agent to overcome the neutrophil's powerful microbicidal mechanisms. 
MATERIALS AND METHODS
Ehrlichia culture. HGE agent, HZ strain, was cultured in the HL-60 human promyelocytic leukemia cell line in RPMI 1640 medium as previously described (19) . When ϳ75% of the HL-60 cells were infected as determined by Diff-Quik (Baxter Scientific Products, Obetz, Ohio) staining, cells were harvested for experiments.
Preparation of neutrophils and mononuclear cells. Human buffy coat (ϳ50 ml) from healthy donors was centrifuged at 1,500 ϫ g for 5 min. Following centrifugation, the plasma was removed, and 10 ml of buffy coat was placed in a 50-ml centrifuge tube containing 10 ml of Histopaque 1077 overlaying 15 ml of Histopaque 1119 (Sigma Chemical Co., St. Louis, Mo.). Following centrifugation at 2,200 ϫ g for 25 min, the interface between Histopaque 1077 and Histopaque 1119 was collected and added to 0.83% NH 4 Cl for 5 min at room temperature to lyse any remaining red blood cells. Neutrophils were centrifuged at 750 ϫ g for 5 min and washed twice with Hanks' balanced salt solution (HBSS) without phenol red and sodium bicarbonate (Sigma). By Diff-Quik staining, cells were determined to be ϳ97% neutrophils. The viability of the neutrophil preparations was determined before and after each experiment by trypan blue exclusion and was found to be ϳ99%. Mononuclear cells in the interface overlaying Histopaque 1077 from the same donor were also collected.
Ferricytochrome c reduction assay. Extracellular O 2 Ϫ was measured on the basis of the superoxide dismutase (SOD)-inhibitable reduction of ferricytochrome c as described by Johnston (12) . Briefly, 2 ϫ 10 6 neutrophils per 50 l of HBSS containing 2 mg of dextrose per ml (HBSSd) were added to the wells of a 24-well plate containing 300 l of reaction mixture with 80 M ferricytochrome c type III from horse heart (Sigma) and with or without SOD (50 g/ml) from bovine erythrocytes (Sigma). Freshly prepared host cell-free intact HGE agent from 2 ϫ 10 6 infected HL-60 cells, or HL-60 cell lysate (obtained by sonication of 2 ϫ 10 6 uninfected cells) as a control, in 50 l of HBSSd was added to neutrophils in triplicate wells and incubated for 30 min at 37°C in 5% CO 2 -95% air. Dose dependency was determined by adding the host cell-free HGE agent in 1ϫ, 10ϫ, and 100ϫ dilutions. To examine the effect of the recombinant major outer membrane 44-kDa protein (rP44) (27) , rP44 (2.5 g/ml) was added in place of host cell-free HGE agent. Lysed HGE agent was prepared by strong sonication (setting 7 for 10 s) of host cell-free HGE agent derived from 2 ϫ 10 6 infected HL-60 cells in 50 l of HBSSd. Mixtures were then stimulated by adding PMA (0.5 g/ml, final concentration; Sigma) and incubated for 2 h at 37°C in 5% CO 2 -95% air. Alternatively, the mixtures were stimulated with 1 M N-formylMet-Leu-Phe (fMLP; Sigma) or 2 ϫ 10 6 Escherichia coli strain INV␣FЈ cells in 50 l of HBSSd. The A 550 of the supernatants was measured in a model DU-70 spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.). The average of A 550 of three wells of cytochrome c blanks was subtracted from individual A 550 of sample wells. The nanomoles of cytochrome c reduced was calculated from the A 550 using the extinction coefficient ⌬E ϭ 21.0 ϫ 10 3 m Ϫ1 cm
Ϫ1
. To consider individual human variations, all experiments were independently repeated more than three times on different days using neutrophils derived from different donors and freshly prepared host cell-free HGE agent. Donor cells were never mixed, and each donor's neutrophil assay included positive and negative controls to ensure the quality of both neutrophil and HGE agent preparation. Pronase treatment of neutrophils preincubated with HGE agent or neuraminidase treatment. Neutrophils were incubated for 30 min at 37°C in HBSSd in the presence or absence of host cell-free HGE agent in HBSSd. Following incubation, pronase E (2 mg/ml; Sigma) was added and incubated for 30 min at 37°C to remove uninternalized host cell-bound HGE agent. Cells were then washed by centrifugation at 1,500 ϫ g for 5 min. For neuraminidase treatment, neutrophils were incubated with or without neuraminidase type X (Sigma) at 1 U/ml for 2 h at 37°C in 0.5 ml of 0.15 M NaCl-5 mM CaCl 2 (pH 6.0) and washed in RPMI 1640 medium.
Treatment of host cell-free HGE agent. Host cell-free HGE agent was incubated with 20 mM sodium periodate (Sigma) in 50 mM sodium acetate buffer (pH 4.5) at room temperature for 1 h in the dark as described by Woodward et al. (25) . Following a brief rinse with 50 mM sodium acetate, ehrlichiae were incubated with 50 mM sodium borohydride (Sigma) in phosphate-buffered saline at room temperature for 30 min. Ehrlichiae were then centrifuged and resuspended in HBSSd. For trypsin treatment, host cell-free HGE agent was incubated in a 0.25% trypsin (Sigma) in HBSSd for 15 min at room temperature, and ehrlichiae were washed twice in HBSSd.
Effects of oxytetracycline or cycloheximide on inhibition of O 2 ؊ generation by the HGE agent. Host cell-free HGE agent was treated with 10 g of oxytetracycline/ml for 30 min at 37°C in 5% CO 2 -95% air and added to neutrophils in HBSSd containing 10 g of oxytetracycline/ml. Neutrophils were incubated in the presence of cycloheximide (2 g/ml) for 30 min at 37°C prior to addition of host cell-free HGE agent and/or PMA. Reagents were present throughout the ferricytochrome c reduction assay.
RESULTS

Upon exposure to neutrophils, the HGE agent did not induce extracellular O 2
؊ release and prevented O 2 ؊ release in response to PMA, E. coli, or fMLP. The normally dormant NADPH oxidase can be activated by either receptor-depen- b Mean Ϯ standard deviation (n ϭ 3). Results are representative of three independent experiments. ‫,ء‬ P Ͻ 0.01 compared to neutrophil-alone (no PMA) control (Student's t test). dent mechanisms (fMLP, various bacteria, Fc receptor crosslinking, complement factor C5a, or zymosan) or receptor-independent mechanisms (PMA [a protein kinase C {PKC} activator] or long-chained unsaturated fatty acids) (1, 20) . In vitro, the HGE agent did not induce extracellular O 2 Ϫ release by human peripheral blood neutrophils when measured by the ferricytochrome c reduction assay (Table 1) . PMA, E. coli, and fMLP all induced significant levels of O 2 Ϫ release, an effect that was inhibitable by addition of nonpermeable SOD to the incubation medium (Table 1 ; Fig. 1 ). Host cell-free HGE agent added 30 min prior to the addition of PMA, E. coli, or fMLP almost completely blocked O 2 Ϫ release for the 2-h incubation period ( Fig. 1; Table 1) ; therefore, the inhibition does not appear to be a delay in enzyme activation. Since the HGE agent was cultivated in HL-60 cells, neutrophils were also incubated with uninfected HL-60 cell lysate to ensure that neutrophils were not inhibited by HL-60 cell components. A level of O 2 Ϫ release similar to that without HL-60 cell lysate was detected in response to PMA. The responses of neutrophils from several donors were similar (Fig. 1) . The viability of the human neutrophil preparations as determined at the end of incubation period (2 to 3 h) for each experiment was ϳ99%.
The Ϫ in salmonella-containing vacuoles, so that intracellular salmonellae can survive (23) . Luminol is a small membrane-permeable molecule that can be used to measure total (intra-and extracellular) O 2 Ϫ production (8). We found that the HGE agent completely prevented total O 2 Ϫ production by neutrophils in response to PMA and E. coli (Fig.  2) for the entire 2-h stimulation period. This result also supports our observation in the ferricytochrome c reduction assay that the inhibition is not simply a delay in enzyme activation but rather complete inhibition. At least 30 min of preincubation with the HGE agent was required for complete cessation of total O 2 Ϫ production in response to PMA. Addition of the HGE agent 10 or 20 min prior to PMA stimulation partially reduced and delayed the total O 2 Ϫ production by neutrophils in response to PMA (data not shown).
Inhibitory effects of the HGE agent on O 2 ؊ release were dose dependent. O 2 Ϫ release in response to PMA was completely prevented with approximately 40 bacteria per neutrophil (Fig. 3) . Use of Ͻ1 organism per neutrophil resulted in no inhibition.
Contact was required. Neutrophils incubated with the HGE agent in an insert separated by a porous membrane from neutrophils in Transwell plates produced levels of extracellular O 2 Ϫ nearly identical to those produced by neutrophils without host cell-free HGE agent stimulated with PMA (Table 2) . In contrast, when ehrlichiae were added directly to wells containing neutrophils (as for Fig. 1 but in a Transwell) , the PMAinduced O 2 Ϫ release was blocked. Host cell-free HGE agent incubated for 30 min with PMA prior to addition to the Transwell did not block the O 2 Ϫ release (data not shown), indicating that PMA was not directly inactivated by ehrlichial organisms. These results suggest that inhibition of the NADPH oxidase system by the HGE agent requires contact between host cell and ehrlichia and that soluble factors released by HGE agent (if any) likely are not involved. 
Inhibition of O 2
؊ release in response to PMA was reversible upon pronase treatment. When neutrophils preincubated with the HGE agent for 30 min were further incubated with pronase to remove bound extracellular HGE agent, neutrophils regained responsiveness to subsequent PMA stimulation. Pronase treatment alone, in the absence of the HGE agent, had no influence on O 2 Ϫ release in response to PMA (Table 2 ). This result suggests that for inhibition of O 2 Ϫ release to occur, the HGE agent must remain associated with the neutrophil and that the HGE agent does not permanently alter the cellular components or cell signaling pathways of the host cell involved in O 2 Ϫ release. Neuraminidase treatment did not prevent O 2 ؊ release inhibition by the HGE agent. A recent study by Goodman et al. (10) has shown that treatment of HL-60 cells with neuraminidase prevents both binding and infection by the HGE agent. To examine whether an external sialic acid on the neutrophil surface is required for inhibition of O 2 Ϫ release by the HGE agent, neutrophils were pretreated with neuraminidase prior to incubation with the HGE agent. Preincubation of neutrophils with neuraminidase alone induced extracellular O 2 Ϫ release that was further enhanced by the addition of PMA (Fig. 4) . Neutrophils preincubated with buffer alone showed no stimulatory or inhibitory effects with or without PMA. The HGE agent completely inhibited O 2 Ϫ release by neuraminidasetreated neutrophils in the presence or absence of PMA. Unlike the case for HL-60 cells (10) , treatment of neutrophils with neuraminidase did not inhibit infection by the HGE agent. Following 16 h of incubation, distinct morulae (microcolonies of ehrlichiae) were present in 6.2% Ϯ 0.5% and 4.1% Ϯ 0.5% (n ϭ 3) of nontreated and treated neutrophils, respectively. The percentage of morula-positive cells, though small, is the percentage normally seen in patient blood (26) . These results indicate that HGE agent infection and HGE agent-dependent inhibition of O 2 Ϫ release are not dependent on an external sialic acid on the neutrophil surface.
Ehrlichial carbohydrate but not protein was required for O 2 ؊ inhibition by the HGE agent. Sodium periodate treatment inactivated the ability of the HGE agent to inhibit O 2 Ϫ release in response to PMA, whereas the HGE agent retained the ability to block O 2 Ϫ release after trypsin treatment ( Table 2 ). The trypsin treatment was sufficient for ehrlichiae to lose infectivity. These results suggest that a carbohydrate moiety but not surface protein of the HGE agent is required for inhibition of the O 2 Ϫ release by PMA. The major surface 44-kDa protein of the HGE agent was previously cloned and expressed, and the recombinant protein was designated rP44 (27) . Although rP44 was shown to interact and induce proinflammatory cytokine gene expression in peripheral blood leukocytes (14) , it did not inhibit the PMA-induced O 2 Ϫ release (data not shown), suggesting that the 44-kDa major outer membrane protein of the HGE agent is not responsible for the inhibition of O 2 Ϫ release.
Ehrlichial new protein synthesis or intact structure was not required. To examine whether the HGE agent requires new protein synthesis to inhibit extracellular O 2 Ϫ generation by the host cell, we preincubated host cell-free HGE agent in the presence of oxytetracycline, a bacteriostatic antibiotic that inhibits new protein synthesis by acting on the 30S ribosome (6) . Preincubation of bacteria with oxytetracycline did not reverse b Mean Ϯ standard deviation (n ϭ 3). Results are representative of more than three independent experiments. ‫,ء‬ P Ͻ 0.01 compared to neutrophil-alone (no PMA) control (Student's t test).
c Neutrophils in one chamber were incubated without or with the HGE agent added to the same or another chamber separated by a Nuclepore polycarbonate porous membrane, using two-compartment Transwell plates. PMA was added to all wells.
d Host cell-free HGE agent was treated with 0.25% trypsin for 15 min at room temperature or with 20 mM sodium periodate for 1 h prior to addition to cytochrome c reduction assay mixtures and PMA stimulation.
e Neutrophils were incubated with host cell-free HGE agent for 30 min at 37°C, incubated with pronase E (2 mg/ml) for 30 min at 37°C to remove uninternalized bacteria, then added to cytochrome c reduction assay mixtures, and stimulated with PMA.
f Neutrophils were incubated for 30 min at 37°C with lysed HGE agent prior to PMA stimulation. the inhibitory effects on O 2 Ϫ production by the HGE agent in PMA-stimulated neutrophils (Fig. 5) . Oxytetracycline alone had no effect on O 2 Ϫ production in PMA-stimulated neutrophils. This result suggests that the HGE agent does not require new or ongoing protein synthesis to inhibit O 2 Ϫ production. Furthermore, lysed HGE agent had the same inhibitory effect as intact viable HGE agent, indicating that structural integrity or viability of ehrlichiae is not required for inhibition (Table 2) .
Protein synthesis by neutrophils was involved in inhibition of O 2
؊ release by the HGE agent. Cycloheximide inhibits eukaryotic but not prokaryotic protein synthesis (3). In the presence of cycloheximide, HGE agent inhibition was partially abrogated following stimulation by PMA (Fig. 5) . Cycloheximide alone did not inhibit O 2 Ϫ release in response to PMA. This result indicates that de novo protein synthesis by the host cell is required for complete inhibition of O 2 Ϫ release induced by the HGE agent, suggesting that a host protein that is rapidly turned over is involved in this inhibition.
Human mononuclear cell O 2 ؊ generation in response to PMA was not prevented by the HGE agent. Preincubation of mononuclear cells with the HGE agent reproducibly delayed O 2 Ϫ generation in response to PMA stimulation by several minutes, but a significant level of LDCL was detected (Fig. 6) . Neutrophils from the same donor, when incubated with the HGE agent, did not respond to PMA stimulation (Fig. 6,  inset) , indicating that inhibition of O 2 Ϫ generation by the HGE agent is neutrophil specific.
DISCUSSION
The HGE agent survives and replicates exclusively within inclusions in granulocytes, the primary effector cells of the host's antimicrobial defense. Neutrophils are the most powerful generators of O 2 Ϫ ; upon contact with most bacteria, parasites, or fungi, O 2 Ϫ production is rapidly induced. In this study, we demonstrated that the HGE agent subverts the ability of human neutrophils to generate O 2 Ϫ in response to both soluble stimuli (PMA or fMLP) and powerful particulate stimuli (E. coli) which activate the NADPH oxidase through different signaling pathways (13 (21) . However, viability of the HGE agent was not required. Carbohydrate but not protein of the HGE agent was required for the inhibition, whereas most known microbial factors are proteins (2, 16, 22, 23) . The nature of this carbohydrate remains to be studied. Although ehrlichiae are gram-negative bacteria, this carbohydrate does not seem to be lipopolysaccharide, which primes, rather than inhibits, the NADPH oxidase enzyme for O 2 Ϫ generation, and lipopolysaccharide has not been demonstrated in Ehrlichia spp. The requirement of carbohydrate for inhibition of O 2 Ϫ generation was opposite the requirement for induction of proinflammatory cytokine gene expression or inhibition of apoptosis by the HGE agent (14, 26) , since the latter two require a protein component of the HGE agent but not the carbohydrate moiety (14, 26) . These results indicate that the HGE agent contains both protein and carbohydrate surface components which interact with host cells and induce several divergent cellular responses for its survival.
Ehrlichial inhibition of O 2 Ϫ secretion required contact between the HGE agent and neutrophils. Our results demonstrated a dose-dependent inhibition of O 2 Ϫ production following PMA stimulation of neutrophils that may reflect a need for a critical number of ehrlichia-host cell receptor occupancies to counteract the O 2 Ϫ production signaling pathway activated by PMA. The fact that the inhibition is reversible upon removal of the extracellular HGE agent by pronase treatment suggests that the host cell receptor transducing a signal for the inhibition is a protein. The fact that O 2 Ϫ production by neutrophils but not monocytes is specifically prevented suggests that the receptor is present or active on neutrophils but not on monocytes. The result also suggests that the HGE agent does not infect monocytes because it is killed by reactive oxygen intermediates generated by monocytes.
Our study revealed that complete inhibition of O 2 Ϫ release by the HGE agent requires 30 min, indicating that HGE agent binding and subsequent signaling are slower than PKC-activated production of O 2 Ϫ . A host protein synthesized during this time period may be required for complete inhibition, since incubation of neutrophils with the protein synthesis inhibitor cycloheximide partially abrogated the inhibition of O 2 Ϫ release by the HGE agent. This is similar to results for ehrlichial apoptosis inhibition (26) . The requirement for protein synthesis suggests that the protein(s) involved in inhibition of O 2 Ϫ release or apoptosis is not present in sufficient concentrations or may have a short half-life. Since previous studies have revealed that at 37°C, internalization of Ehrlichia risticii into P388D 1 cells, a murine macrophage cell line, occurs within 3 to 4 h of exposure (17) , the inhibition by the HGE agent most likely occurs upon contact with the host cell prior to internalization.
Neutrophils also can kill invading microorganisms by oxygen-independent mechanisms, such as fusion of the phagosomes containing bacteria with granules containing both antimicrobial peptides (e.g., defensins or lysozymes) and lysosomal hydrolytic enzymes or through sequestering vital nutrients (e.g., iron) (7). We previously found that the inclusion compartments of the HGE agent are unique in lacking both endosomal and lysosomal properties (15) . Therefore, the HGE agent has the ability to block oxygen-dependent and -independent microbicidal mechanisms of neutrophils.
